These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10339663)

  • 1. Retroviruses prepared from human DAF expressing murine packaging cells acquire resistance against human serum.
    Hiasa A; Watanabe M; Okada H; Ikenaka K; Fujita T; Yoshimatsu T; Kanematsu T; Shiku H
    Int J Oncol; 1999 Jun; 14(6):1091-6. PubMed ID: 10339663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta-short consensus repeat 4-decay accelerating factor (DAF: CD55) inhibits complement-mediated cytolysis but not NK cell-mediated cytolysis.
    Miyagawa S; Kubo T; Matsunami K; Kusama T; Beppu K; Nozaki H; Moritan T; Ahn C; Kim JY; Fukuta D; Shirakura R
    J Immunol; 2004 Sep; 173(6):3945-52. PubMed ID: 15356143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquisition of complement resistance through incorporation of CD55/decay-accelerating factor into viral particles bearing baculovirus GP64.
    Kaname Y; Tani H; Kataoka C; Shiokawa M; Taguwa S; Abe T; Moriishi K; Kinoshita T; Matsuura Y
    J Virol; 2010 Apr; 84(7):3210-9. PubMed ID: 20071581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-protected amphotropic retroviruses from murine packaging cells.
    Spitzer D; Hauser H; Wirth D
    Hum Gene Ther; 1999 Jul; 10(11):1893-902. PubMed ID: 10446929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of MLV vector particles from human complement.
    Breun S; Salmons B; Günzburg WH; Baumann JG
    Biochem Biophys Res Commun; 1999 Oct; 264(1):1-5. PubMed ID: 10527830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel bifunctional chimeric complement inhibitor that regulates C3 convertase and formation of the membrane attack complex.
    Fodor WL; Rollins SA; Guilmette ER; Setter E; Squinto SP
    J Immunol; 1995 Nov; 155(9):4135-8. PubMed ID: 7594566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
    Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
    Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities.
    Harris CL; Spiller OB; Morgan BP
    Immunology; 2000 Aug; 100(4):462-70. PubMed ID: 10929073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).
    Karnauchow TM; Tolson DL; Harrison BA; Altman E; Lublin DM; Dimock K
    J Virol; 1996 Aug; 70(8):5143-52. PubMed ID: 8764022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
    Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
    FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transduction via a protein associated with a glycosylphosphatidylinositol-anchored protein, decay-accelerating factor (DAF/CD55).
    Kuraya M; Fujita T
    Int Immunol; 1998 Apr; 10(4):473-80. PubMed ID: 9620603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homologous restriction of complement-mediated cell lysis can be markedly enhanced by blocking decay-accelerating factor.
    Zhong RK; Kozii R; Ball ED
    Br J Haematol; 1995 Oct; 91(2):269-74. PubMed ID: 8547061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.
    Bergelson JM; Chan M; Solomon KR; St John NF; Lin H; Finberg RW
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6245-8. PubMed ID: 7517044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor.
    Coyne KE; Hall SE; Thompson S; Arce MA; Kinoshita T; Fujita T; Anstee DJ; Rosse W; Lublin DM
    J Immunol; 1992 Nov; 149(9):2906-13. PubMed ID: 1383332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human complement-dependent cell lysis by bovine aortic endothelial cells transfected with membrane-bound complement-regulatory factor (DAF and HRF20) gene using a retroviral vector.
    Hayashi S; Isobe K; Emi N; Yokoyama I; Okada H; Nakashima I; Takagi H
    Eur Surg Res; 1996; 28(6):440-6. PubMed ID: 8954321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
    Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
    Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
    Lublin DM; Coyne KE
    J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of human decay-accelerating factor in the evasion of Schistosoma mansoni from the complement-mediated killing in vitro.
    Horta MF; Ramalho-Pinto FJ
    J Exp Med; 1991 Dec; 174(6):1399-406. PubMed ID: 1720809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement.
    Marschang P; Sodroski J; Würzner R; Dierich MP
    Eur J Immunol; 1995 Jan; 25(1):285-90. PubMed ID: 7531147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines.
    Russell DW; Berger MS; Miller AD
    Hum Gene Ther; 1995 May; 6(5):635-41. PubMed ID: 7578400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.